Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 8:9:91.
doi: 10.3389/fnana.2015.00091. eCollection 2015.

Oxidative stress and Parkinson's disease

Affiliations
Review

Oxidative stress and Parkinson's disease

Javier Blesa et al. Front Neuroanat. .

Abstract

Parkinson disease (PD) is a chronic, progressive neurological disease that is associated with a loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. The molecular mechanisms underlying the loss of these neurons still remain elusive. Oxidative stress is thought to play an important role in dopaminergic neurotoxicity. Complex I deficiencies of the respiratory chain account for the majority of unfavorable neuronal degeneration in PD. Environmental factors, such as neurotoxins, pesticides, insecticides, dopamine (DA) itself, and genetic mutations in PD-associated proteins contribute to mitochondrial dysfunction which precedes reactive oxygen species formation. In this mini review, we give an update of the classical pathways involving these mechanisms of neurodegeneration, the biochemical and molecular events that mediate or regulate DA neuronal vulnerability, and the role of PD-related gene products in modulating cellular responses to oxidative stress in the course of the neurodegenerative process.

Keywords: Parkinson disease; dopamine; mitochondrial dysfunction; neuroinflammation; oxidative stress.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Suggested physiological processes related to pathogenesis of Parkinson’s disease (PD). Different pathways and their dysfunctions resulting from genetic modifications in PD-related genes and lead to an increased oxidative stress. Mutations or altered expression of these proteins result in mitochondrial impairment, oxidative stress, and protein misfolding. Also, dopamine metabolism may be oxidized to reactive dopamine quinones contributing to increased levels of reactive oxygen species. α-Synuclein becomes modified and accelerate its aggregation. Increased oxidative stress provokes impaired function of the UPS that degrades misfolded or damaged proteins and hereby further affecting cell survival. Environmental toxins impair mitochondrial function, increase the generation of free radicals, and lead to aggregation of proteins, including α-synuclein. Mitochondrial dysfunction by complex I inhibition affects by adding an increase in oxidative stress and a decline in ATP production, leading to damage of intracellular components and to cell death. Also, neuroinflammatory mechanisms might contribute to the cascade of consequences leading to cell death. In summary, all these several cellular mechanisms attributed to oxidative stress are implicated in the selective degeneration of dopaminergic neurons.

References

    1. Amo T., Saiki S., Sawayama T., Sato S., Hattori N. (2014). Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1. Neurosci. Lett. 580 37–40. 10.1016/j.neulet.2014.07.045 - DOI - PubMed
    1. Amo T., Sato S., Saiki S., Wolf A. M., Toyomizu M., Gautier C. A., et al. (2011). Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects. Neurobiol. Dis. 41 111–118. 10.1016/j.nbd.2010.08.027 - DOI - PubMed
    1. Ares-Santos S., Granado N., Espadas I., Martinez-Murillo R., Moratalla R. (2014). Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology 39 1066–1080. 10.1038/npp.2013.307 - DOI - PMC - PubMed
    1. Asanuma M., Miyazaki I., Ogawa N. (2003). Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease. Neurotox. Res. 5 165–176. 10.1007/BF03033137 - DOI - PubMed
    1. Austin S. A., Floden A. M., Murphy E. J., Combs C. K. (2006). Alpha-synuclein expression modulates microglial activation phenotype. J. Neurosci. 26 10558–10563. 10.1523/JNEUROSCI.1799-06.2006 - DOI - PMC - PubMed